

|
Monday, February 28 1:00 PM Convention Center Room 206


Click on the numbers in parentheses to display abstracts.



Section E - BREAST
Chaired by: Laura C. Collins and Daniel Visscher



| 1:00 |
Should Intraductal Papilloma Diagnosed on Core Needle Biopsy Be Excised?
(157)
S Jaffer, CS Nagi, IJ Bleiweiss - The Mount Sinai Medical Center, New York, NY
|
| 1:15 |
Analysis of Cancer Risk among Patients with Papillary Lesions of the Breast
(172)
JT Lewis, RA Vierkant, SD Maloney, LC Hartmann, DW Visscher - Mayo Clinic, Rochester, MN
|
| 1:30 |
Encysted (Noninvasive) Papillary Carcinomas Are Associated with Pseudoinvasion More Often Than Microinvasion
(114)
BC Calhoun, RA Jensen, JF Simpson, ME Sanders, DL Page - Vanderbilt University Medical Center, Nashville, TN
|
| 1:45 |
Pure Spindle Cell Metaplastic Tumors of the Breast: An Immunohistochemical and Morphologic Study with Follow-Up
(104)
R Barner, GL Bratthauer, FA Tavassoli - Armed Forces Institute of Pathology, Washington, DC; Yale University School of Medicine, New Haven, CT
|
| 2:00 |
Are Metaplastic Breast Carcinomas Basal-Like Tumours?
(206)
JS Reis-Filho, F Milanezi, P Simpson, LG Fulford, D Steele, J Nesland, E Pereira, SR Lakhani, F Schmitt - ICR, London, United Kingdom; Porto, Portugal; Montebello, Norway; Sao Paulo, Brazil; University of Porto, Porto, Portugal
|
| 2:15 |
Stromal Expression Signatures Predict Outcome in Breast Carcinoma
(240)
RB West, DSA Nuyten, S Subramanian, CL Corless, BP Rubin, K Montgomery, SX Zhu, TO Nielsen, R Patel, JR Goldblum, PO Brown, M van de Vijver, M van de Rijn - Stanford University Medical Center, Palo Alto, CA; Netherlands Cancer Institute, Amsterdam, Netherlands; University of Washington Medical Center, Seattle, WA; Vancouver General Hospital, Vancouver, BC, Canada; Cleveland Clinic Foundation, Cleveland, OH; Oregon Health & Science University Cancer Institute, Portland, OR; Emory University School of Medicine, Atlanta, GA
|
| 2:30 |
Selection and Utility of a Panel of Early Stage Breast Cancer Prognostic Molecular Markers
(241)
CM Whitehead, R Nelson, R Hudson, M Gore, T Sporn, J Hessling, R Marcelpoil, D Morel, D Malinowski, T Fischer - Tripath Oncology, Durham, NC
|
| 2:45 |
GATA3 Expression in Breast Cancer: A Strong Independent Predictor of Survival
(184)
R Mehra, R Shen, S Varambally, AM Chinnaiyan, CG Kleer - University of Michigan, Ann Arbor, MI
|
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
|
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Dr. Phillip A. Sharp
The Biological and Potentially Therapeutic Activities of Short RNAs
Convention Center, Ballroom B
|

|



|